ClinVar Miner

Submissions for variant NM_001177316.2(SLC34A3):c.1247del (p.Leu416fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Neuberg Centre For Genomic Medicine, NCGM RCV003388712 SCV004100440 likely pathogenic Autosomal recessive hypophosphatemic bone disease criteria provided, single submitter clinical testing The frameshift deletion p.L416Pfs*65 in SLC34A3 (NM_001177316.2) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.L416Pfs*65 variant is observed in 8/30,598 (0.0261%) alleles from individuals of South Asian background in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant is predicted to cause loss of normal protein function through protein truncation. For these reasons, this variant has been classified as Likely Pathogenic. In the absence of another reportable variant, the molecuar diagnosis is not confirmed.
Labcorp Genetics (formerly Invitae), Labcorp RCV003669404 SCV004384736 pathogenic not provided 2024-01-19 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Leu416Profs*65) in the SLC34A3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 184 amino acid(s) of the SLC34A3 protein. This variant is present in population databases (rs781602446, gnomAD 0.03%). This premature translational stop signal has been observed in individual(s) with urinary stone disease (PMID: 34805638). ClinVar contains an entry for this variant (Variation ID: 2627449). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts a region of the SLC34A3 protein in which other variant(s) (p.Trp541*) have been determined to be pathogenic (PMID: 31440709). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.